CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 40 enrolled
Drug / intervention
CYT005-AllQbG10 (combination of house dust mite allergen extract with CYT003-QbG10) +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00574704
NCT00574704Phase 2Completed
CompareCT.gov

Double Blind Placebo Controlled Study to Assess Efficacy and Safety of a Combined Allergen Vaccine (CYT005-AllQbG10) and Its Single Components in Patients With House Dust Mite Allergy

Cytos Biotechnology AG·interventional·Posted Dec 17, 2007·Updated Jul 11, 2013

In Brief

A Phase 2 clinical trial evaluating CYT005-AllQbG10 (combination of house dust mite allergen extract with CYT003-QbG10), House dust mite allergen extract in combination with CYT003-QbG10-placebo, and 2 other interventions for Perennial Allergic Rhinoconjunctivitis and House Dust Mite Allergy. Completed, enrolled 40 participants.

Detailed Summary

The purpose of the study is to test the efficacy of the combination treatment AllQbG10 in patients with perennial allergic rhinoconjunctivitis due to house dust mite allergy in a double-blind, placebo-controlled setting

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPerennial Allergic Rhinoconjunctivitis, House Dust Mite Allergy
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 17, 2007
Enrollment StartSep 1, 2006
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 18.5 years ago

Interventions

CYT005-AllQbG10 (combination of house dust mite allergen extract with CYT003-QbG10)drug

subcutaneous injections at 6 visits

House dust mite allergen extract in combination with CYT003-QbG10-placebodrug

subcutaneous injections at 6 visits

CYT003-AllQbG10 in combination with house dust mite allergen extract placebodrug

subcutaneous injections at 6 visits

CYT003-QbG10-placebo in combination with house dust mite allergen extract placebodrug

subcutaneous injections at 6 visits